Histopathologic diagnosis of prostate cancer

A histopathologic diagnosis of prostate cancer is the discernment of whether there is a cancer in the prostate, as well as specifying any subdiagnosis of prostate cancer if possible. The histopathologic subdiagnosis of prostate cancer has implications for the possibility and methodology of any subsequent Gleason scoring.[1] The most common histopathological subdiagnosis of prostate cancer is acinar adenocarcinoma, constituting 93% of prostate cancers.[2] The most common form of acinar adenocarcinoma, in turn, is "adenocarcinoma, not otherwise specified", also termed conventional, or usual acinar adenocarcinoma.[3]

  1. ^ Li J, Wang Z (February 2016). "The pathology of unusual subtypes of prostate cancer". Chin. J. Cancer Res. 28 (1): 130–43. doi:10.3978/j.issn.1000-9604.2016.01.06. PMC 4779761. PMID 27041935.
  2. ^ Baig, Faraz A.; Hamid, Amna; Mirza, Talat; Syed, Serajuddaula (2015). "Ductal and Acinar Adenocarcinoma of Prostate: Morphological and Immunohistochemical Characterization". Oman Medical Journal. 30 (3): 162–166. doi:10.5001/omj.2015.36. ISSN 1999-768X. PMC 4459157. PMID 26171121.
  3. ^ "Prostatic Adenocarcinoma". Stanford University School of Medicine. Archived from the original on 2019-09-11. Retrieved 2019-10-30.